Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Samsara BioCapital (US)

Samsara BioCapital is a new breed of biotech investment fund focused on translating cutting-edge biology into new therapies to treat patients with unmet medical needs. Founded in 2016 by Srinivas Akkaraju, MD, PhD, our team of scientists, investors, and entrepreneurs takes a long-term view to value creation across all stages of public and private life science companies. We believe in a collaborative, hands-on approach, working closely with entrepreneurs to harness exciting scientific advances and build leading companies. Samsara actively manages approximately US$410 million in assets on behalf of endowments, foundations, and family offices. *


Period Start 2016-01-01 established
Products Industry venture capital
  Industry 2 BIOTECH
Persons Person Akkaraju, Srinivas (Samsara BioCaptial 2016– Founder)
  Person 2 Freedland, Cory S. (Samsara BioCapital 202007 Principal before Sofinnova 201703 at Sofinnnova Ventures)
  Street 628 Middlefield Road
  City 94301 Palo Alto, CA
    Address record changed: 2020-12-02
Basic data Employees n. a.
  Currency USD
  Annual sales 410,000,000 (assets, managed (2020) 2020-09-16)
    * Document for �About Section�: Graphite Bio. (9/16/20). "Press Release: Graphite Bio Launches with $45 Million Series A Financing". South San Francisco, CA.
Record changed: 2021-04-05


Picture [iito] Plain Stupid Simple 650x80px

More documents for Samsara BioCapital (US)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Hotspot for Startups 650x80px

» top